Description
Doxoday-650 Tablets are formulated with Doxofylline 650 mg in a modified-release form, designed to provide sustained bronchodilatory action for patients suffering from respiratory disorders. Doxofylline belongs to the class of xanthine derivatives, which are known for their bronchodilator properties and are widely used in the treatment of obstructive airway diseases.
Doxofylline works by relaxing the smooth muscles of the bronchial airways, helping to widen the air passages and improve airflow to the lungs. This helps relieve symptoms such as shortness of breath, wheezing, chest tightness, and coughing associated with respiratory conditions.
The modified-release formulation ensures a controlled and prolonged release of the active ingredient, helping maintain consistent therapeutic levels in the body over an extended period. This can improve treatment effectiveness and patient compliance by reducing the frequency of dosing.
Doxoday-650 Tablets are commonly prescribed for the management of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions where bronchodilation is required. The medication should be taken strictly according to the advice of a qualified healthcare professional.
Indications
Doxoday-650 Tablets are indicated for the management of respiratory conditions such as:
-
Bronchial Asthma
-
Chronic Obstructive Pulmonary Disease (COPD)
-
Chronic Bronchitis
-
Other obstructive airway diseases
Dosage and Administration
Doxoday-650 Tablets should be administered only under the supervision of a qualified healthcare professional.
-
Dosage should be taken as prescribed by a healthcare professional.
-
The tablet should be swallowed whole with water, preferably after meals.
-
Do not crush or chew the modified-release tablet unless directed by a physician.
Safety Information
-
For prescription use only.
-
Use under the guidance of a registered medical practitioner.
-
Patients with heart disease, liver disorders, or kidney problems should consult a physician before use.
-
Not recommended in case of known hypersensitivity to xanthine derivatives.
